Cancer Family
Soft Tissue Neoplasm
CI-CAN-00000354Explore in graph →
Non-malignant441 active trials9 approved drugs183 evidence items
Loading cancer entity…
Cancer Family
CI-CAN-00000354Explore in graph →
Clinical trials
2,078 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT05238831 | SMMART Adaptive Clinical Treatment (ACT) Trial | withdrawn | Early Phase 1 | 0 | OHSU Knight Cancer InstituteOTHER | 0 | Jan 23, 2024 | clinicaltrials |
| NCT04877587 | Gemcitabine With Ascorbate Including Adolescents | withdrawn | Early Phase 1 | 0 | David DickensOTHER | 1 | Feb 22, 2023 | clinicaltrials |
| NCT03613259 |
| Fluorothymidine F-18 PET in Diagnosing Patients With Intermediate or High Grade Soft Tissue Sarcoma |
| withdrawn |
| Early Phase 1 |
| 0 |
| OHSU Knight Cancer InstituteOTHER |
| 0 |
| Jun 9, 2020 |
| clinicaltrials |
Data updated 23 days agoSource updated Jan 23, 2024source: clinicaltrials